垂体瘤诊断与治疗中的受体显像 - Suppr

Suppr

超能文献

Receptor imaging in the diagnosis and treatment of pituitary tumors.

作者信息

Kwekkeboom D J, de Herder W W, Krenning E P

机构信息

Department of Nuclear Medicine, University Hospital Dijkzigt, Rotterdam, The Netherlands.

出版信息

J Endocrinol Invest. 1999 Jan;22(1):80-8. doi: 10.1007/BF03345484.

DOI:10.1007/BF03345484

PMID:10090143

Abstract

摘要

相似文献

Receptor imaging in the diagnosis and treatment of pituitary tumors.垂体瘤诊断与治疗中的受体显像

J Endocrinol Invest. 1999 Jan;22(1):80-8. doi: 10.1007/BF03345484.

Receptor imaging in the diagnosis and treatment of pituitary tumors.垂体瘤诊断与治疗中的受体显像

J Endocrinol Invest. 1999 Oct;22(9):736-7. doi: 10.1007/BF03343636.

[Diagnostic imaging of a TSH-producing pituitary adenoma associated with the "empty sella" by somatostatin and dopamine D2 receptor scintigraphy].[生长抑素和多巴胺D2受体闪烁扫描法对与“空蝶鞍”相关的促甲状腺激素分泌型垂体腺瘤的诊断性成像]

Nuklearmedizin. 2000;39(1):42-5.

The somatostatin receptor--a window of therapeutic opportunity?生长抑素受体——治疗机会之窗？

Endocrinology. 1995 Sep;136(9):3695-7. doi: 10.1210/endo.136.9.7649074.

In vivo visualization of pituitary dopaminergic receptors by iodine-123 methoxybenzamide (IBZM) correlates with sensitivity to dopamine agonists in two patients with macroprolactinomas.通过碘-123甲氧基苄胺（IBZM）对两名大泌乳素瘤患者的垂体多巴胺能受体进行体内可视化，这与对多巴胺激动剂的敏感性相关。

J Clin Endocrinol Metab. 1995 Aug;80(8):2523-5. doi: 10.1210/jcem.80.8.7629253.

In vivo measurement of dopamine receptors in pituitary adenomas using positron emission tomography.使用正电子发射断层扫描技术对垂体腺瘤中的多巴胺受体进行体内测量。

Acta Radiol Suppl. 1986;369:406-8.

Heterogeneous expression of two somatostatin receptor subtypes in pituitary tumors.垂体瘤中两种生长抑素受体亚型的异质性表达。

J Clin Endocrinol Metab. 1994 Feb;78(2):398-403. doi: 10.1210/jcem.78.2.8106629.

[What is your diagnosis? (Atypical) bronchial carcinoid, Cushing syndrome due to ectopic ACTH production (somatostatin receptor positive tumor). Incidentaloma of the hypophysis].你的诊断是什么？（非典型）支气管类癌，异位促肾上腺皮质激素分泌所致库欣综合征（生长抑素受体阳性肿瘤）。垂体偶发瘤。

Praxis (Bern 1994). 2001 Mar 1;90(9):337-8.

Single photon emission computed tomography procedure improves accuracy of somatostatin receptor scintigraphy in gastro-entero pancreatic tumours.单光子发射计算机断层扫描程序提高了生长抑素受体闪烁显像在胃肠胰肿瘤中的准确性。

Ital J Gastroenterol Hepatol. 1999 Oct;31 Suppl 2:S186-9.

Somatostatin receptor tumor imaging (Tc 99m P829) in pituitary adenoma.垂体腺瘤中的生长抑素受体肿瘤显像（锝99m P829）

J Med Assoc Thai. 1999 Dec;82(12):1208-13.

引用本文的文献

Somatostatin receptor SPECT.生长抑素受体 SPECT。

Eur J Nucl Med Mol Imaging. 2012 Feb;39 Suppl 1:S41-51. doi: 10.1007/s00259-011-2019-2.

First demonstration of the effectiveness of peptide receptor radionuclide therapy (PRRT) with 111In-DTPA-octreotide in a giant PRL-secreting pituitary adenoma resistant to conventional treatment.首例经皮腔内血管成形术治疗伴颅内巨大动脉瘤的颈动脉狭窄的疗效分析

Pituitary. 2012 Dec;15 Suppl 1:S57-60. doi: 10.1007/s11102-011-0373-5.

Somatostatin receptor imaging for neuroendocrine tumors.神经内分泌肿瘤的生长抑素受体显像

Pituitary. 2006;9(3):243-8. doi: 10.1007/s11102-006-0270-5.

Octreoscan radioreceptor imaging.奥曲肽扫描放射性受体显像

Endocrine. 2003 Apr;20(3):307-11. doi: 10.1385/ENDO:20:3:307.

Somatostatin analog therapy in treatment of gastrointestinal disorders and tumors.生长抑素类似物疗法在胃肠道疾病和肿瘤治疗中的应用

Endocrine. 2003 Apr;20(3):285-90. doi: 10.1385/ENDO:20:3:285.

Receptor imaging in the diagnosis and treatment of pituitary tumors.垂体瘤诊断与治疗中的受体显像

J Endocrinol Invest. 1999 Oct;22(9):736-7. doi: 10.1007/BF03343636.

本文引用的文献

Comparison of iodine-123 epidepride and iodine-123 IBZM for dopamine D2 receptor imaging in clinically non-functioning pituitary macroadenomas and macroprolactinomas.碘-123 表哌立得与碘-123 IBZM 在临床无功能垂体大腺瘤和大泌乳素瘤多巴胺 D2 受体显像中的比较。

Eur J Nucl Med. 1999 Jan;26(1):46-50. doi: 10.1007/s002590050358.

Somatostatin receptor imaging in somatotroph and non-functioning pituitary adenomas: correlation with hormonal and visual responses to octreotide.生长激素细胞腺瘤和无功能垂体腺瘤中的生长抑素受体显像：与对奥曲肽的激素及视觉反应的相关性

Clin Endocrinol (Oxf). 1997 Nov;47(5):589-98. doi: 10.1046/j.1365-2265.1997.3361119.x.

111Indium-pentetreotide pituitary scintigraphy and hormonal responses to octreotide in acromegalic patients.111铟-喷替酸奥曲肽垂体闪烁扫描术及肢端肥大症患者对奥曲肽的激素反应

J Endocrinol Invest. 1997 Jul-Aug;20(7):424-8. doi: 10.1007/BF03347995.

Indium-111 pentetreotide single-photon emission tomography in patients with TSH-secreting pituitary adenomas: correlation with the effect of a single administration of octreotide on serum TSH levels.促甲状腺激素分泌型垂体腺瘤患者的铟-111 五肽胃泌素单光子发射断层扫描：与单次注射奥曲肽对血清促甲状腺激素水平的影响的相关性

Eur J Nucl Med. 1997 Jul;24(7):728-31. doi: 10.1007/BF00879659.

Results of somatostatin receptor scintigraphy do not predict pituitary tumor volume- and hormone-response to ocreotide therapy and do not correlate with tumor histology.生长抑素受体闪烁扫描的结果无法预测垂体瘤体积及对奥曲肽治疗的激素反应，且与肿瘤组织学无关。

Eur J Endocrinol. 1997 Apr;136(4):369-76. doi: 10.1530/eje.0.1360369.

In vivo imaging of pituitary tumours using a radiolabelled dopamine D2 receptor radioligand.使用放射性标记的多巴胺D2受体放射性配体对垂体肿瘤进行体内成像。

Clin Endocrinol (Oxf). 1996 Dec;45(6):755-67. doi: 10.1046/j.1365-2265.1996.8650876.x.

Scintigraphic assessment of pituitary adenomas and several diseases by indium-111-pentetreotide.铟-111-五肽胃泌素对垂体腺瘤及多种疾病的闪烁显像评估

Q J Nucl Med. 1995 Dec;39(4 Suppl 1):98-100.

[111In-DTPA-D-Phe]-octreotide scintigraphy in functioning and non-functioning pituitary adenomas.[111铟-二乙三胺五乙酸-D-苯丙氨酸]奥曲肽闪烁扫描术在功能性和无功能性垂体腺瘤中的应用

Q J Nucl Med. 1995 Dec;39(4 Suppl 1):90-3.

Dopamine D2 receptor imaging in pituitary adenomas using iodine-123-epidepride and SPECT.使用碘-123-表阿朴吗啡和单光子发射计算机断层扫描对垂体腺瘤进行多巴胺D2受体成像。

J Nucl Med. 1996 Dec;37(12):1931-7.

Comparison of iodine-123-epidepride and iodine-123-IBZM for dopamine D2 receptor imaging.碘-123-表哌立松与碘-123-碘苄胍用于多巴胺D2受体显像的比较。

J Nucl Med. 1996 Oct;37(10):1589-91.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验